cropped color_logo_with_background.png

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Study Purpose

This pilot, non-interventional, observational, Web-based, prospective cohort study is designed to collect self-reported safety and effectiveness and genetic data from subjects with locally recurrent breast cancer (BC) or metastatic breast cancer (MBC), metastatic colorectal cancer (MCRC), metastatic non-squamous non-small cell lung cancer (MNSCLC), recurrent glioblastoma (RGBM), or metastatic renal cell cancer (MRCC) in the United States who have been previously treated with Avastin (bevacizumab). The cohort will be composed of male and female subjects who have been diagnosed with locally recurrent BC or MBC, MCRC, MNSCLC, RGBM, or MRCC who have received treatment with bevacizumab in combination with chemotherapy, which started prior to or up to 31 December 2012. Participants will be self-referred to this study. They will be recruited online via a number of sources, including through the involvement of patient advocacy groups, social media tools, traditional media, physicians, and events to raise awareness of this study. After appropriate informed consent and authorization are obtained, data will be collected directly from subjects in an online survey. Participants will be contacted electronically to complete quarterly follow-up surveys. The follow-up period will be 1 year from responding to the baseline survey. DNA collection will be performed as part of this study. DNA will be extracted from saliva, which will be provided by the subject utilizing a collection kit sent to the participants for at-home use.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational
Eligible Ages 18 Years and Over
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Locally recurrent BC or MBC, MCRC, MNSCLC, RGBM, or MRCC in patients treated or on treatment with bevacizumab, which started prior to or up to 31 December 2012.
  • - Ability to read and understand English.
  • - Ability to access and use a computer connected to the Internet.
  • - Signed informed consent and authorization form.
  • - Residence in the United States.
  • - At least 18 years of age.

Exclusion Criteria:

N/A

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT01598597
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Genentech, Inc.
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Clinical Trials
Principal Investigator Affiliation Genentech, Inc.
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Industry
Overall Status Completed
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma, Renal Cell Cancer
Arms & Interventions

Arms

: Cohort

Interventions

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Many locations, Alabama

Status

Address

Many locations, Alabama,

Many locations, Alaska

Status

Address

Many locations, Alaska,

Many locations, Arizona

Status

Address

Many locations, Arizona,

Many locations, Arkansas

Status

Address

Many locations, Arkansas,

Many locations, California

Status

Address

Many locations, California,

Many locations, Colorado

Status

Address

Many locations, Colorado,

Many locations, Connecticut

Status

Address

Many locations, Connecticut,

Many locations, Delaware

Status

Address

Many locations, Delaware,

Many locations, Florida

Status

Address

Many locations, Florida,

Many locations, Georgia

Status

Address

Many locations, Georgia,

Many locations, Hawaii

Status

Address

Many locations, Hawaii,

Many locations, Idaho

Status

Address

Many locations, Idaho,

Many locations, Illinois

Status

Address

Many locations, Illinois,

Many locations, Indiana

Status

Address

Many locations, Indiana,

Many locations, Iowa

Status

Address

Many locations, Iowa,

Many locations, Kansas

Status

Address

Many locations, Kansas,

Many locations, Kentucky

Status

Address

Many locations, Kentucky,

Many locations, Louisiana

Status

Address

Many locations, Louisiana,

Many locations, Maine

Status

Address

Many locations, Maine,

Many locations, Maryland

Status

Address

Many locations, Maryland,

Many locations, Massachusetts

Status

Address

Many locations, Massachusetts,

Many locations, Michigan

Status

Address

Many locations, Michigan,

Many locations, Minnesota

Status

Address

Many locations, Minnesota,

Many locations, Mississippi

Status

Address

Many locations, Mississippi,

Many locations, Missouri

Status

Address

Many locations, Missouri,

Many locations, Montana

Status

Address

Many locations, Montana,

Many locations, Nebraska

Status

Address

Many locations, Nebraska,

Many locations, Nevada

Status

Address

Many locations, Nevada,

Many locations, New Hampshire

Status

Address

Many locations, New Hampshire,

Many locations, New Jersey

Status

Address

Many locations, New Jersey,

Many locations, New Mexico

Status

Address

Many locations, New Mexico,

Many locations, New York

Status

Address

Many locations, New York,

Many locations, North Carolina

Status

Address

Many locations, North Carolina,

Many locations, North Dakota

Status

Address

Many locations, North Dakota,

Many locations, Ohio

Status

Address

Many locations, Ohio,

Many locations, Oklahoma

Status

Address

Many locations, Oklahoma,

Many locations, Oregon

Status

Address

Many locations, Oregon,

Many locations, Pennsylvania

Status

Address

Many locations, Pennsylvania,

Many locations, Rhode Island

Status

Address

Many locations, Rhode Island,

Many locations, South Carolina

Status

Address

Many locations, South Carolina,

Many locations, South Dakota

Status

Address

Many locations, South Dakota,

Many locations, Tennessee

Status

Address

Many locations, Tennessee,

Many locations, Texas

Status

Address

Many locations, Texas,

Many locations, Utah

Status

Address

Many locations, Utah,

Many locations, Vermont

Status

Address

Many locations, Vermont,

Many locations, Virginia

Status

Address

Many locations, Virginia,

Many locations, Washington

Status

Address

Many locations, Washington,

Many locations, West Virginia

Status

Address

Many locations, West Virginia,

Many locations, Wisconsin

Status

Address

Many locations, Wisconsin,

Many locations, Wyoming

Status

Address

Many locations, Wyoming,